相关实验视频
Updated: Feb 4, 2026

08:43
Orthotopic Mouse Model of Colorectal Cancer
Published on: December 4, 2007
47.2K
IER3通过NF-κB途径促进结肠直肠癌恶性进展
Zhigang Wei1,2, Yinyi Luo3, Yupeng Zhang3
1Department of Pathology, School of Basic Medical Science, Shanxi Medical University, Taiyuan, China, sxmu.edu.cn.
International journal of genomics
|February 2, 2026
概括
应激反应基因IER3通过激活关键信号通路促进结直肠癌 (CRC) 的生长和扩散. 准IER3可能为治疗侵略性CRC和克服免疫逃避提供新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 转移和免疫抑制瘤免疫微环境 (TIME) 是CRC治疗的关键挑战.
- 应激反应基因IER3在CRC病原和免疫调节中的作用尚不清楚.
研究的目的:
- 研究IER3在结直肠癌进展中的功能作用.
- 探索IER3对瘤免疫微环境的影响.
- 确定IER3作为CRC中的潜在治疗标和生物标志物.
主要方法:
- 临床CRC样本的综合单细胞RNA测序 (scRNA-seq).
- 在体外和体外功能研究,以评估IER3对CRC细胞的影响.
- 对TNF-α/NF-κB信号通路和免疫细胞相互作用的分析.
主要成果:
- 在CRC中,一个明显的IE3表达的恶性亚群与侵袭性疾病和不良预后有关.
- IER3通过激活TNF-α/NF-κB通路来促进CRC的扩散,入侵和转移.
- IER3+恶性细胞通过改变的免疫细胞透和FN1-CD44轴诱导免疫抑制时间.
- 高IER3表达与免疫检查点阻塞 (ICB) 的反应降低和特定药物敏感性相关.
结论:
- IER3是CRC进展和免疫逃逸的关键调解者.
- IER3 是结直肠癌的一个有前途的治疗点.
- IER3表达水平可以作为预测治疗反应和指导个性化治疗的生物标志物.
相关概念视频
NF-κB-dependent Signaling Pathway
10.0K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.0K
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
The Eukaryotic Promoter Region
18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region
3.9K
3.9K
C4 Pathway and CAM
49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K

